ReviewFrontiers in oncology2021

Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019.

Xuetong Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.